Founded in 2004, l’institut du thorax is devoted to patient care, research and higher education in cardiovascular, metabolic ... and respiratory diseases. From bench to bedside, our scope reaches from a basic research lab (Inserm UMR 1087/CNRS UMR 6291) to clinical departments via a clinical investigation center. Based in Nantes –Western France- our 800 clinicians, healthcare professionals, research scientists and professors share a common culture: cross-pollination to foster excellence and imagine innovative multidisciplinary projects to provide patients with high-quality treatments and medical care. Within just a few years, our clinicians and research scientists developed novel approaches that led to the implementation of translational research programs. Besides, our discoveries, scientific publications and collaborations put Nantes and French cardiovascular and metabolic research on the global map, ranking among the best teams. Our excellence enables us to attract young and talented colleagues: our latest newcomers joined us from- among others- Massachusetts General Hospital (Boston, USA), Harvard School of Public Health (Boston, USA), University of California – San Francisco (USA), Amsterdam Medical Center (The Netherlands), Sanger Institute (Cambridge, UK) or Mayo Clinic (Rochester, USA). How about you ? L’institut du thorax at a glance: ·800 staff members among which 85 physicians and 140 basic research staff ·5 basic research teams at Nantes University, labelled by the National Institute of Health and Medical Research (Inserm) and the Centre National de Recherche Scientifique (CNRS) ·74 students: 26 PhD students and 48 residents ·6 clinical departments at Nantes University Hospital: Cardiology and Vascular Diseases, Vascular Surgery, Cardiovascular and Thoracic Surgery, Thoracic Transplant Unit, Endocrinology, Metabolic Diseases and Nutrition, Pneumology ·1 Clinical Research Department with 40 clinical research nurses and technicians ·2 National Centers labelled by the French Ministry of Health for Hereditary Rhythmic Diseases and Cystic Fibrosis ·3 high-tech genomics, bioinformatics and small animal function testing platforms more than EUR10M/year dedicated to our research ·120 medical and scientific publications per year (among which 7% in the global top 1%) ·Many fundings won to build strong French and international research consortia (e.g.1 DHU, 1 RHU and 4 Leducq networks) ·Medical experts chosen by the French Ministry of Health to launch high-tech innovative techniques ·Teams involved in the implantations of the Carmat artificial heart ·Genavie, a foundation that participates in launching audacious and innovative projects developed by the research teams of l’institut du thorax. read more